Klausner Richard

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 44% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Klausner Richard's trades of Lyell Immunopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-18 2025-03-14
B Purchase
97,747 +18.3%
223.87
US$4,306,765 		97,747 +18.3% 223.87 US$4,306,765
2023-08-17 2023-08-15
S Sale
82,632 +1.4%
495.18
US$517,041 		82,632 +1.4% 495.18 US$517,041
2023-08-15 2023-08-15
PrS Proposed sale
80,288
443.94
US$4,306,008 		80,288 443.94 US$4,306,008
2023-08-15 2023-08-15
PrS Proposed sale
4,485
2.29
US$10,271 		4,485 2.29 US$10,271
2023-08-15 2023-08-15
PrS Proposed sale
44,565
2.29
US$102,054 		44,565 2.29 US$102,054
2023-08-15 2023-08-15
PrS Proposed sale
4,485
2.29
US$10,271 		4,485 2.29 US$10,271
2023-07-17 2023-07-13
PrS Proposed sale
14,500
2.90
US$42,050 		14,500 2.90 US$42,050
2023-07-17 2023-07-13
PrS Proposed sale
3,300
2.90
US$9,570 		3,300 2.90 US$9,570
2023-07-17 2023-07-13
PrS Proposed sale
3,300
2.90
US$9,570 		3,300 2.90 US$9,570
2023-07-17 2023-07-13
PrS Proposed sale
3,300
2.90
US$9,570 		3,300 2.90 US$9,570
2022-09-27 2022-09-23
S Sale
11,100 -1.1%
6.40
US$71,041 		11,100 -1.1% 6.40 US$71,041